Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
The pathogenesis of autoimmune liver disease and autoimmunity associated with chronic viral hepatitis remains poorly understood. One of the major hurdles to a deeper understanding of these pathological processes is the absence of clearly defined inductive mechanisms, which, if identified and characterised, could guide clinical strategies for their prevention or allow therapeutic intervention. Molecular mimicry leading to crossreactive autoimmune responses has gained strong experimental support in the past decade. A fundamental premise of this hypothesis is the involvement of a mimicking environmental trigger. In view of the numerous viral and bacterial agents epidemiologically linked to autoimmune liver diseases, we and others have proposed molecular mimicry to be an important mechanism in these diseases. We also propose similar crossreactive mechanisms to operate in the generation of autoimmunity in viral hepatitis. This review focuses on molecular mimicry at the level of the B-cell, as few data on T-cell crossreactivity in liver disease are thus far available.
Bogdanos
D P
DP
Immunology Group, Institute of Hepatology, University College London Medical School, London, UK.
Choudhuri
K
K
Vergani
D
D
D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D015551:Autoimmunity; D001402:B-Lymphocytes / Q000276:immunology; D006525:Hepatitis, Viral, Human / Q000209:etiology / Q000276:immunology / Q000628:therapy; D006801:Humans; D008107:Liver Diseases / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology